Adult Stem Cell Company Reports on Heart Therapy
The adult stem cell company Cardio3 BioSciences presents an update on its heart failure therapy at the annual conference of the European Society of Cardiology.
August 31, 2009
The adult stem cell company Cardio3 BioSciences presents an update on its heart failure therapy at the annual conference of the European Society of Cardiology.
Scientists create insulin-producing cells from iPS cells derived from the skin of people with Type I diabetes.
Surgeons in England are repairing damaged bones, joints and cartilage with adult stem cells, thereby rendering hip replacements unnecessary.
BioLife Solutions launches its new biopreservation platform, which improves upon methods for the cryopreservation of adult stem cells derived from umbilical cord blood and peripheral blood.
The biotech company BrainStorm Cell Therapeutics enters into an agreement for the production of clinical-grade adult stem cells as a treatment of ALS.
Recent studies indicate that a lack of public education about cord-blood-derived adult stem cells is hindering therapeutic progress.